Speciality Medicines Ltd vs Vasundhara Rasayans Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Speciality Medicines Ltd is ₹ 301.15 as of 05 May 15:30 . The P/E Ratio of Speciality Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vasundhara Rasayans Ltd changed from 7.6 on March 2021 to 17.3 on March 2025 . This represents a CAGR of 17.88% over 5 years The Market Cap of Speciality Medicines Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vasundhara Rasayans Ltd changed from ₹ 22.22 crore on March 2021 to ₹ 73.37 crore on March 2025 . This represents a CAGR of 26.99% over 5 years The revenue of Speciality Medicines Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vasundhara Rasayans Ltd for the Dec '25 is ₹ 8.12 crore as compare to the Sep '25 revenue of ₹ 9.68 crore. This represent the decline of -16.12% The ebitda of Speciality Medicines Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vasundhara Rasayans Ltd for the Dec '25 is ₹ 1.18 crore as compare to the Sep '25 ebitda of ₹ 2.98 crore. This represent the decline of -60.4% The net profit of Speciality Medicines Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Vasundhara Rasayans Ltd changed from ₹ 0.86 crore to ₹ 0.72 crore over 7 quarters. This represents a CAGR of -9.65% The Dividend Payout of Speciality Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vasundhara Rasayans Ltd changed from 16.22 % on March 2021 to 14.96 % on March 2025 . This represents a CAGR of -1.60% over 5 years .

About Speciality Medicines Ltd

Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet.

About Vasundhara Rasayans Ltd

Vasundhara Rasayans Limited was incorporated in March, 1987.
The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual capacity of about 1500 MT of powder or its equivalent products.
It started its operation in year 1990 with an Antacid API facility offering product in paste, powder and micronised grade of powder. The plant is located on National Highway between Mumbai and Goa in an Industrial Zone called Mahad which is about 170 KMS from Mumbai and about 125 KMS from the NSICT /JNPT Ports Mumbai.
In addition to the API manufacturing Vasundhara is also having an API intermediate plant to handle organic products with its state of the art specialised Friedel Craft reaction facility. The manufacturing area is maintained as per GMP standards.

FAQs for the comparison of Speciality Medicines Ltd and Vasundhara Rasayans Ltd

Which company has a larger market capitalization, Speciality Medicines Ltd or Vasundhara Rasayans Ltd?

Market cap of Speciality Medicines Ltd is 264 Cr while Market cap of Vasundhara Rasayans Ltd is 41 Cr

What are the key factors driving the stock performance of Speciality Medicines Ltd and Vasundhara Rasayans Ltd?

The stock performance of Speciality Medicines Ltd and Vasundhara Rasayans Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Speciality Medicines Ltd and Vasundhara Rasayans Ltd?

As of May 5, 2026, the Speciality Medicines Ltd stock price is INR ₹301.15. On the other hand, Vasundhara Rasayans Ltd stock price is INR ₹132.0.

How do dividend payouts of Speciality Medicines Ltd and Vasundhara Rasayans Ltd compare?

To compare the dividend payouts of Speciality Medicines Ltd and Vasundhara Rasayans Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.